Senti Biosciences Holdings, Inc. (SNTI) Operating cash flow 2021–2025
Senti Biosciences Holdings, Inc. (SNTI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$43.4MFY2025 · since FY2021: -$34.6M → -$43.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$43.4M | -4.9% |
| FY2024 | -$41.4M | +21.0% |
| FY2023 | -$52.4M | -50.1% |
| FY2022 | -$34.9M | -0.8% |
| FY2021 | -$34.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SNTI financial trends
SNTI RevenueSNTI Net incomeSNTI Net marginSNTI Gross profitSNTI Gross marginSNTI Operating incomeSNTI Operating marginSNTI Free cash flowSNTI Capital expendituresSNTI Return on equitySNTI Stock buybacksSNTI Dividends paidSNTI Total assetsSNTI Total liabilitiesSNTI Shareholders’ equitySNTI overview →